Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Principia Biopharma
Biotech
Sanofi cuts programs tied to multibillion-dollar deals
Sanofi scratched out entries for prospects linked to the multibillion-dollar takeovers of Ablynx, Principia Biopharma and Synthorx.
Nick Paul Taylor
Jan 30, 2025 9:05am
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Apr 23, 2024 2:23am
Sanofi reports setbacks to Denali, Kymab and Principia assets
Oct 27, 2023 6:25am
Still under partial hold, Sanofi makes case for safety of MS med
Apr 28, 2023 11:16am
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
Apr 27, 2023 7:41am
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
Feb 3, 2023 6:50am
